HealthcareGlobe NewsPress Releases

Drug and Gene Delivery Market Reaches $ 815 Bn By 2030

Share This Article

According to the industry experts, The drug and gene delivery devices market size is projected to reach around US$ 815 billion by 2030 from USD 410 billion in 2021 growing at a CAGR of 7.2% from 2021 to 2030. The report contains 150+ pages with detailed analysis.

The base year for the study has been considered 2021, the historic year 2019 and 2020, the forecast period considered is from 2021 to 2030. The drug and gene delivery devices market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit).

Drug and Gene Delivery Devices Market Size 2020 to 2030

Download the Sample Pages of this Report for Better Understanding (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1388

Drug and Gene Delivery Devices Market Scope

This market report studies market dynamics, status and outlook especially in North America, Europe and Asia-Pacific, Latin America, the Middle East and Africa. This research report offers scenario and forecast (revenue/volume), and categorizes the market by key players and various segment. This report also studies global market prominence, competitive landscape, market share, growth rates market dynamics such as drivers, restraints and opportunities, and distributors and sales channels.

This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

The global drug and gene delivery devices market is primarily driven by the rising prevalence of various chronic diseases such as cancer, diabetes, and cardiovascular diseases among the global population. The rapid growth of the biopharmaceuticals industry resulted in the development of various therapeutics and gene therapeutics that can effectively treat various chronic diseases and genetic diseases. The rising adoption of such drugs among the population is boosting the growth of the global drug and gene delivery devices market.

Furthermore, the rising investments by the market players in the research and development of the drug delivery systems are fostering the market growth. The technological advancements are providing easy to use and convenient administration of drugs through various roots, which is expected to drive the drug and gene delivery devices market across the globe.

 Drug and Gene Delivery Devices Market Coverage 

Report Coverage Details
Market Size in 2021 USD 410 Billion
Growth Rate From 2021 to 2030 CAGR of 7.2%
Fastest Growing Market Asia Pacific
Largest Market North America
Base Year 2021
Forecast Period 2021 to 2030

Asia Pacific is estimated to be the fastest-growing market during the forecast period. The presence of several top biopharmaceutical companies in the nations like India, China, and South Korea is propelling the market growth. The presence of huge population and rising prevalence of chronic diseases among the population is a major factor that is expected to drive the growth of the drug and gene delivery devices market in the region. Furthermore, the rising popularity of the personalized medicines among the population to treat genetic disorder may have a positive impact on the market. The rapid industrialization in the region is resulting in pollution that further propels the number of respiratory diseases among the population. Therefore, the rising number of disease due to the rising pollution levels in the region is expected to offer lucrative growth opportunities to the market players in the upcoming future.

The rising number of approvals for the newly developed therapeutics across the globe is expected to have a positive impact on the market. The major approving authorities such as FDA and EMA are very much active in monitoring the clinical trials of various medicines and diagnostic methods.

The stringent government regulations pertaining the drug and gene delivery devices and the infections and injuries caused by the injectable are the two major restraining factors that may hamper the growth of the global drug and gene delivery devices market during the forecast period.

Based on the delivery type, the injectable is estimated to be the most opportunistic segment during the forecast period. This can be attributed to the development and rising popularity of various injectable such as pen-injectors, self-injectors, and auto-injectors that emerged as a result of the technological advancements in the market. The rising number of diabetic population who needs to inject insulin as a diabetes management measure is expected to drive the growth of this segment. Moreover, the convenience associated with the injectable may boost the adoption of the injectable in the forthcoming years.

Based on the method, the in situ segment dominated the market in 2020. This can be attributed to the certain advantages associated with the in situ method such as low complication in fabrication and ease of drug administration. Moreover, the majority of the drugs that are currently used follows the in situ method.

Based on the vector, the viral vector segment dominated the market in 2020. This is due to the increased usage of the viral vectors for the majority of the clinical trials. Moreover, the rising prevalence of genetic disorders and chronic diseases among the global population is further fueling the segment growth. The extensive use of the viral vectors in the development of drugs and gene therapies has significantly contributed towards the growth of the segment in the past.

More Links:

Key Players/Manufacturers

This report also provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the drug and gene delivery devices market and ranks noticeable companies as per their occurrence in diverse regions across the globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.

Some of the prominent players in the global drug and gene delivery devices market include:

  • Pfizer, Inc.
  • F. Hoffmann-La Roche Ltd
  • Johnson and Johnson Private Ltd
  • Novartis AG
  • Bayer AG
  • Becton, Dickinson and Company
  • Uniqure NV

Market Segments Covered in the Report

By Delivery Type

  • Oral
  • Ocular
  • Inhalation
  • Nasal
  • Injectable
  • Transdermal
  • Topical

By Method

  • In Situ
  • Ex Vivo

By Vector

  • Viral Vector
  • Non-Viral Vector

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Research Objective

  • To provide a comprehensive analysis of the drug and gene delivery devices industry and its sub-segments in the global market, thereby providing a detailed structure of the industry
  • To provide detailed insights into factors driving and restraining the growth of this global market
  • To provide a distribution chain analysis/value chain for the this market
  • To estimate the market size of the global drug and gene delivery devices market where 2019 would be the historical period, 2020 shall be the base year, and 2020 to 2027 will be the forecast period for the study
  • To provide strategic profiling of key companies (manufacturers and distributors) present across the globe, and comprehensively analyze their competitiveness/competitive landscape in this market
  • To analyze the global market in four main geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World
  • To provide country-wise market value analysis for various segments of the drug and gene delivery devices

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Drug and Gene Delivery Devices Market 

5.1. COVID-19 Landscape: Drug and Gene Delivery Devices Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Drug and Gene Delivery Devices Market, By Delivery

8.1. Drug and Gene Delivery Devices Market, by Delivery Type, 2021-2030

8.1.1. Oral

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Ocular

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Inhalation

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Nasal

8.1.4.1. Market Revenue and Forecast (2019-2030)

8.1.5. Injectable

8.1.5.1. Market Revenue and Forecast (2019-2030)

8.1.6. Transdermal

8.1.6.1. Market Revenue and Forecast (2019-2030)

8.1.7. Topical

8.1.7.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Drug and Gene Delivery Devices Market, By Method

9.1. Drug and Gene Delivery Devices Market, by Method, 2021-2030

9.1.1. In Situ

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Ex Vivo

9.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Drug and Gene Delivery Devices Market, By Vector 

10.1. Drug and Gene Delivery Devices Market, by Vector, 2021-2030

10.1.1. Viral Vector

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Non-Viral Vector

10.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Drug and Gene Delivery Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.1.2. Market Revenue and Forecast, by Method (2019-2030)

11.1.3. Market Revenue and Forecast, by Vector (2019-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.1.4.2. Market Revenue and Forecast, by Method (2019-2030)

11.1.4.3. Market Revenue and Forecast, by Vector (2019-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.1.5.2. Market Revenue and Forecast, by Method (2019-2030)

11.1.5.3. Market Revenue and Forecast, by Vector (2019-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.2.2. Market Revenue and Forecast, by Method (2019-2030)

11.2.3. Market Revenue and Forecast, by Vector (2019-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.2.4.2. Market Revenue and Forecast, by Method (2019-2030)

11.2.4.3. Market Revenue and Forecast, by Vector (2019-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.2.5.2. Market Revenue and Forecast, by Method (2019-2030)

11.2.5.3. Market Revenue and Forecast, by Vector (2019-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.2.6.2. Market Revenue and Forecast, by Method (2019-2030)

11.2.6.3. Market Revenue and Forecast, by Vector (2019-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.2.7.2. Market Revenue and Forecast, by Method (2019-2030)

11.2.7.3. Market Revenue and Forecast, by Vector (2019-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.3.2. Market Revenue and Forecast, by Method (2019-2030)

11.3.3. Market Revenue and Forecast, by Vector (2019-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.3.4.2. Market Revenue and Forecast, by Method (2019-2030)

11.3.4.3. Market Revenue and Forecast, by Vector (2019-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.3.5.2. Market Revenue and Forecast, by Method (2019-2030)

11.3.5.3. Market Revenue and Forecast, by Vector (2019-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.3.6.2. Market Revenue and Forecast, by Method (2019-2030)

11.3.6.3. Market Revenue and Forecast, by Vector (2019-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.3.7.2. Market Revenue and Forecast, by Method (2019-2030)

11.3.7.3. Market Revenue and Forecast, by Vector (2019-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.4.2. Market Revenue and Forecast, by Method (2019-2030)

11.4.3. Market Revenue and Forecast, by Vector (2019-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.4.4.2. Market Revenue and Forecast, by Method (2019-2030)

11.4.4.3. Market Revenue and Forecast, by Vector (2019-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.4.5.2. Market Revenue and Forecast, by Method (2019-2030)

11.4.5.3. Market Revenue and Forecast, by Vector (2019-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.4.6.2. Market Revenue and Forecast, by Method (2019-2030)

11.4.6.3. Market Revenue and Forecast, by Vector (2019-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.4.7.2. Market Revenue and Forecast, by Method (2019-2030)

11.4.7.3. Market Revenue and Forecast, by Vector (2019-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.5.2. Market Revenue and Forecast, by Method (2019-2030)

11.5.3. Market Revenue and Forecast, by Vector (2019-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.5.4.2. Market Revenue and Forecast, by Method (2019-2030)

11.5.4.3. Market Revenue and Forecast, by Vector (2019-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Delivery (2019-2030)

11.5.5.2. Market Revenue and Forecast, by Method (2019-2030)

11.5.5.3. Market Revenue and Forecast, by Vector (2019-2030)

Chapter 12. Company Profiles

12.1. Pfizer, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. F. Hoffmann-La Roche Ltd

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Johnson and Johnson Private Ltd

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Novartis AG

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Bayer AG

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Becton, Dickinson and Company

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Uniqure NV

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Why Buy this Report?

The purpose of Precedence Research’s drug and gene delivery devices market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1388

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Frequently Asked Questions
[WPSM_AC id=6537]
Show More

Market Stats News

Market Stats News is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services, we aim at connecting an organization’s goal with lucrative prospects globally.

Related Articles

Back to top button